Capital International’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99M | Sell |
61,552
-10,511
| -15% | -$511K | 0.11% | 126 |
|
|
2025
Q1 | $2.45M | Sell |
72,063
-56,317
| -44% | -$1.92M | 0.11% | 127 |
|
|
2024
Q4 | $5.05M | Buy |
128,380
+2,776
| +2% | +$109K | 0.21% | 104 |
|
|
2024
Q3 | $5.9M | Sell |
125,604
-527
| -0.4% | -$24.8K | 0.25% | 95 |
|
|
2024
Q2 | $6.81M | Sell |
126,131
-639
| -0.5% | -$34.5K | 0.31% | 81 |
|
|
2024
Q1 | $8.64M | Buy |
126,770
+31,908
| +34% | +$2.17M | 0.41% | 74 |
|
|
2023
Q4 | $5.94M | Sell |
94,862
-108
| -0.1% | -$6.76K | 0.3% | 89 |
|
|
2023
Q3 | $4.31M | Sell |
94,970
-182
| -0.2% | -$8.26K | 0.25% | 102 |
|
|
2023
Q2 | $5.34M | Buy |
95,152
+2,618
| +3% | +$147K | 0.3% | 94 |
|
|
2023
Q1 | $4.19M | Buy |
92,534
+14,234
| +18% | +$644K | 0.25% | 110 |
|
|
2022
Q4 | $3.18M | Buy |
78,300
+2,215
| +3% | +$90K | 0.22% | 115 |
|
|
2022
Q3 | $4.97M | Buy |
76,085
+27,936
| +58% | +$1.83M | 0.35% | 81 |
|
|
2022
Q2 | $2.93M | Buy |
48,149
+4,912
| +11% | +$299K | 0.22% | 106 |
|
|
2022
Q1 | $2.71M | Hold |
43,237
| – | – | 0.15% | 121 |
|
|
2021
Q4 | $3.28M | Buy |
43,237
+2,838
| +7% | +$215K | 0.17% | 122 |
|
|
2021
Q3 | $4.52M | Buy |
40,399
+452
| +1% | +$50.6K | 0.25% | 102 |
|
|
2021
Q2 | $6.47M | Sell |
39,947
-4,451
| -10% | -$721K | 0.36% | 75 |
|
|
2021
Q1 | $5.41M | Sell |
44,398
-24,951
| -36% | -$3.04M | 0.33% | 90 |
|
|
2020
Q4 | $10.6M | Buy |
69,349
+916
| +1% | +$140K | 0.62% | 44 |
|
|
2020
Q3 | $5.72M | Buy |
+68,433
| New | +$5.72M | 0.39% | 66 |
|